Development of growth factor fusion proteins for cell-triggered drug delivery.
Sakiyama-Elbert
S E
SE
Department of Materials and Institute for Biomedical Engineering, ETH-Zurich and University of Zurich, Zurich, Switzerland.
Panitch
A
A
Hubbell
J A
JA
D000818:Animals; D015153:Blotting, Western; D002642:Chick Embryo; D016503:Drug Delivery Systems / Q000379:methods*; D005109:Extracellular Matrix; D005337:Fibrin / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism*; D005727:Ganglia, Spinal / Q000166:cytology; D006801:Humans; D020932:Nerve Growth Factor / Q000008:administration & dosage* / Q000235:genetics / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D016716:PC12 Cells; D051381:Rats; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage* / Q000235:genetics / Q000378:metabolism; D011503:Transglutaminases / Q000235:genetics / Q000378:metabolism
D011993:Recombinant Fusion Proteins; D005337:Fibrin; D020932:Nerve Growth Factor; D011503:Transglutaminases; D005341:Fibrinolysin